The National Institute for Health and Care Excellence (NICE) has recommended amivantamab (Rybrevant) plus lazertinib ...

AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview – AstraZeneca is launching a phase II, single‑arm trial ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Researchers at the Massachusetts Institute of Technology and Stanford University have reported a novel immunotherapy strategy ...

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...

The need for dialysis depends on symptoms, the cause of the problem, and overall kidney function, not just one lab result ...